BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P. Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases. PLoS One 2015;10:e0117420. [PMID: 25700262 DOI: 10.1371/journal.pone.0117420] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Di Bona D, Aiello A, Colomba C, Bilancia M, Accardi G, Rubino R, Giannitrapani L, Tuttolomondo A, Cascio A, Caiaffa MF, Rizzo S, Di Lorenzo G, Candore G, Duro G, Macchia L, Montalto G, Caruso C; KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. J Viral Hepat 2017;24:768-75. [PMID: 28211154 DOI: 10.1111/jvh.12698] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
2 Umemura T, Joshita S, Saito H, Wakabayashi SI, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Ota M. Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients. Cancers (Basel) 2021;13:3267. [PMID: 34209910 DOI: 10.3390/cancers13133267] [Reference Citation Analysis]
3 Walker AJ, Peacock CJ, Pedergnana V, Irving WL; STOP-HCV Consortium. Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review. J Viral Hepat 2018;25:442-56. [PMID: 29397014 DOI: 10.1111/jvh.12871] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
4 Berretta M, Cavaliere C, Alessandrini L, Stanzione B, Facchini G, Balestreri L, Perin T, Canzonieri V. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget. 2017;8:14192-14220. [PMID: 28077782 DOI: 10.18632/oncotarget.13929] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
5 Pymm P, Vivian JP. Production of Recombinant Killer Immunoglobulin-Like Receptors for Crystallography and Luminex-Based Assays. Methods Mol Biol 2018;1725:281-99. [PMID: 29322425 DOI: 10.1007/978-1-4939-7568-6_22] [Reference Citation Analysis]
6 O'Brien TR, Yang HI, Groover S, Jeng WJ. Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression. Gastroenterology 2019;156:400-17. [PMID: 30287169 DOI: 10.1053/j.gastro.2018.09.052] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
7 Rizzo S, Schiuma G, Beltrami S, Gentili V, Rizzo R, Bortolotti D. Role of KIR Receptor in NK Regulation during Viral Infections. Immuno 2021;1:305-31. [DOI: 10.3390/immuno1030021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li Q, Liu S, Zhang S, Liu C, Sun M, Li C, Zhang X, Chen J, Yao Y, Shi L. Human leucocyte antigen but not KIR alleles and haplotypes associated with chronic HCV infection in a Chinese Han population. Int J Immunogenet 2019;46:263-73. [PMID: 30932338 DOI: 10.1111/iji.12425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Augusto DG, Petzl-Erler ML. KIR and HLA under pressure: evidences of coevolution across worldwide populations. Hum Genet 2015;134:929-40. [PMID: 26099314 DOI: 10.1007/s00439-015-1579-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
10 Huth TK, Brenu EW, Staines DR, Marshall-Gradisnik SM. Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients. Gene Regul Syst Bio 2016;10:43-9. [PMID: 27346947 DOI: 10.4137/GRSB.S39861] [Reference Citation Analysis]
11 Legrand N, David G, Rodallec A, Gaultier A, Salmon D, Cesbron A, Wittkop L, Raffi F, Gendzekhadze K, Retière C, Allavena C, Gagne K. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals. Clin Exp Immunol 2021;204:107-24. [PMID: 33314121 DOI: 10.1111/cei.13562] [Reference Citation Analysis]
12 Yu M, Li Z. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches. Front Med 2017;11:509-21. [DOI: 10.1007/s11684-017-0546-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
13 Papúchová H, Meissner TB, Li Q, Strominger JL, Tilburgs T. The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface. Front Immunol 2019;10:2730. [PMID: 31921098 DOI: 10.3389/fimmu.2019.02730] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
14 Rossetto A, De Re V, Steffan A, Ravaioli M, Miolo G, Leone P, Racanelli V, Uzzau A, Baccarani U, Cescon M. Carcinogenesis and Metastasis in Liver: Cell Physiological Basis. Cancers (Basel) 2019;11:E1731. [PMID: 31694274 DOI: 10.3390/cancers11111731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
15 Assone T, Paiva A, Fonseca LA, Casseb J. Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections. Viruses 2016;8:E38. [PMID: 26848682 DOI: 10.3390/v8020038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
16 Ruiz-Extremera A, Pavón-Castillero EJ, Florido M, Muñoz de Rueda P, Muñoz-Gámez JA, Casado J, Carazo A, Quiles R, Jiménez-Ruiz SM, Gila A, Luna JD, León J, Salmerón J. Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children. PLoS One 2017;12:e0172527. [PMID: 28225833 DOI: 10.1371/journal.pone.0172527] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pezzuto F, Buonaguro L, Buonaguro FM, Tornesello ML. Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma. Infect Agent Cancer. 2017;12:27. [PMID: 28529542 DOI: 10.1186/s13027-017-0138-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
18 Shen C, Ge Z, Dong C, Wang C, Shao J, Cai W, Huang P, Fan H, Li J, Zhang Y, Yue M. Genetic Variants in KIR/HLA-C Genes Are Associated With the Susceptibility to HCV Infection in a High-Risk Chinese Population. Front Immunol 2021;12:632353. [PMID: 34220799 DOI: 10.3389/fimmu.2021.632353] [Reference Citation Analysis]
19 Podhorzer A, Dirchwolf M, Machicote A, Belen S, Montal S, Paz S, Fainboim H, Podestá LG, Fainboim L. The Clinical Features of Patients with Chronic Hepatitis C Virus Infections Are Associated with Killer Cell Immunoglobulin-Like Receptor Genes and Their Expression on the Surface of Natural Killer Cells. Front Immunol 2017;8:1912. [PMID: 29354127 DOI: 10.3389/fimmu.2017.01912] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
20 Ferreira JM, Santos LDS, Oliveira SP, Dos Santos BRC, Dos Santos ACM, de Moura EL, de Souza EVM, de Lima Filho JL. Chikungunya Virus Infection Outcome: A Systematic Review of Host Genetics. Immunol Invest 2021;50:58-79. [PMID: 32204641 DOI: 10.1080/08820139.2020.1733011] [Reference Citation Analysis]
21 De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P. Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases. PLoS One 2015;10:e0128849. [PMID: 25978365 DOI: 10.1371/journal.pone.0128849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Feder S, Haberl EM, Spirk M, Weiss TS, Wiest R, Buechler C. Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients. Clin Exp Med 2020;20:289-97. [PMID: 32078718 DOI: 10.1007/s10238-020-00617-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Mele D, Pasi A, Cacciatore R, Mantovani S, Oliviero B, Mondelli MU, Varchetta S. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection. Liver Int 2019;39:1237-45. [PMID: 31177636 DOI: 10.1111/liv.14172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Couronné L, Bachy E, Roulland S, Nadel B, Davi F, Armand M, Canioni D, Michot JM, Visco C, Arcaini L, Besson C, Hermine O. From hepatitis C virus infection to B-cell lymphoma. Ann Oncol 2018;29:92-100. [PMID: 29045541 DOI: 10.1093/annonc/mdx635] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
25 Savoy SKA, Boudreau JE. The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control. Viruses 2019;11:E959. [PMID: 31627371 DOI: 10.3390/v11100959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
26 Carloni G, Fioretti D, Rinaldi M, Ponzetto A. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas. Crit Rev Oncol Hematol 2019;138:156-71. [PMID: 31092372 DOI: 10.1016/j.critrevonc.2019.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Retamozo S, Quartuccio L, Ramos-Casals M. Cryoglobulinemia. Med Clin (Barc) 2022:S0025-7753(21)00735-1. [PMID: 35216803 DOI: 10.1016/j.medcli.2021.11.017] [Reference Citation Analysis]
28 Ursu LD, Calenic B, Diculescu M, Dima A, Stoian IT, Constantinescu I. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients. Int J Immunogenet 2021;48:16-24. [PMID: 32961633 DOI: 10.1111/iji.12515] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Garozzo A, Falzone L, Rapisarda V, Marconi A, Cinà D, Fenga C, Spandidos DA, Libra M. The risk of HCV infection among health-care workers and its association with extrahepatic manifestations (Review). Mol Med Rep 2017;15:3336-9. [PMID: 28339065 DOI: 10.3892/mmr.2017.6378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
30 Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M. KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients. Oncotarget 2018;9:19650-61. [PMID: 29731972 DOI: 10.18632/oncotarget.24752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
31 Shmeleva EV, Colucci F. Maternal natural killer cells at the intersection between reproduction and mucosal immunity. Mucosal Immunol 2021;14:991-1005. [PMID: 33903735 DOI: 10.1038/s41385-020-00374-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Singh KK, Qin M, Brummel SS, Angelidou K, Trout RN, Fenton T, Spector SA. Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children. PLoS One 2016;11:e0151364. [PMID: 26983081 DOI: 10.1371/journal.pone.0151364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2. Oncotarget 2016;7:37487-97. [PMID: 27183918 DOI: 10.18632/oncotarget.9303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
34 Boudreau JE, Hsu KC. Natural killer cell education in human health and disease. Curr Opin Immunol 2018;50:102-11. [PMID: 29413815 DOI: 10.1016/j.coi.2017.11.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 14.8] [Reference Citation Analysis]
35 Mhandire K, Zijenah LS, Yindom LM, Duri K, Mlambo T, Tshabalala M, Mazengera LR, Mhandire DZ, Musarurwa C, Dandara C, Rowland-Jones S, Matarira HT, Stray-Pedersen B. KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection? OMICS 2016;20:727-35. [PMID: 27930093 DOI: 10.1089/omi.2016.0154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
36 Aguiar VRC, Augusto DG, Castelli EC, Hollenbach JA, Meyer D, Nunes K, Petzl-Erler ML. An immunogenetic view of COVID-19. Genet Mol Biol 2021;44:e20210036. [PMID: 34436508 DOI: 10.1590/1678-4685-GMB-2021-0036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Frias M, Rivero-Juárez A, Rodriguez-Cano D, Camacho Á, López-López P, Risalde MÁ, Manzanares-Martín B, Brieva T, Machuca I, Rivero A. HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance. Sci Rep 2018;8:659. [PMID: 29330418 DOI: 10.1038/s41598-017-17531-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 Crespo ÂC, Strominger JL, Tilburgs T. Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection. Proc Natl Acad Sci U S A 2016;113:15072-7. [PMID: 27956621 DOI: 10.1073/pnas.1617927114] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
39 Shan Z, Huang J, Liao Q, Huang K, Wang M, Xu R, Tang X, Zhang W, Nelson K, Fu Y, Li C, Rong X. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population. Transfusion 2018;58:1028-35. [PMID: 29446443 DOI: 10.1111/trf.14527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]